Pathology Test 1

Front 1

Pathology

Back 1

Study of disease

Front 2

Disease

Back 2

Response of the body to some form of injury.

Front 3

Signs

Back 3

Measurable or objective manifestations

Front 4

Symptoms

Back 4

Feeling that the patient describes. Subjective manifestations.

Front 5

Asymptomatic

Back 5

Without subjective or objective manifestations

Front 6

Etiology

Back 6

Study of the cause of the disease process

Front 7

Iatrogenic infection

Back 7

Disease caused by the physician or treatment

Front 8

Nosocomial infection

Back 8

Infections contracted in acute care facility.

Front 9

Community acquired infection

Back 9

Infections contracted in a public setting outside if the acute care facility

Front 10

Idiopathic

Back 10

Underlying cause is unknown

Front 11

Diagnosis

Back 11

Identification of the disease process

Front 12

Prognosis

Back 12

Probable patient outcome

Front 13

Syndrome

Back 13

Linked combination of signs and symptoms

Front 14

Inflammation

Back 14

Initial repsonse of tissue to local injury

Front 15

Pyogenic bacteria

Back 15

Thick yellow fluid caused by pus (dead white cells)

Front 16

Abscess

Back 16

Localized usually encapsulated collection of fluid

Front 17

Bacteremia

Back 17

Potential involvement of other organs and tissues in the body by organisms invading the blood vessel

Front 18

Edema

Back 18

Accumulation of abnormal amounts of fluid in the intercellular tissue spaces or body cavities

Front 19

Elephantiasis

Back 19

Localized lymphatic obstruction resulting in localized edema

Front 20

Ischemia

Back 20

Interference of blood supply to an organ; deprives cells and tissues of oxygen and nutrients

Front 21

Infarct

Back 21

Localized area of ischemic necrosis; produced by occlusion of either arterial supply or venous drainage

Front 22

Hemorrhage

Back 22

Implies rupture of a blood vessel

Front 23

Hematoma

Back 23

Accumulation of blood trapped within body tissue

Front 24

Petechiae

Back 24

Minimal hemorrhages into the skin, mucous membranes, or serosal surfaces.

Front 25

Purpura

Back 25

Slightly larges hemorrhages

Front 26

Ecchymosis

Back 26

Subcutaneous hematoma;bruise

Front 27

Atrophy

Back 27

Reduction in size or # of cells in an organ or tissue with a corresponding decrease in function

Front 28

Hypertrophy

Back 28

Increase in the size of the cells of a tissue or organ in reponse to a demand for increased function

Front 29

Hyperplasia

Back 29

Increase in the # of cells in a tissue or organ

Front 30

Dsyplasia

Back 30

Loss of uniformity of individual cells and their architechural orientation

Front 31

Neoplasia

Back 31

Ungoverned abnormal proliferation of cells

Front 32

Oncology

Back 32

The study of neoplasms (tumors)

Front 33

Benign

Back 33

Growth that closely resembles the cells of origin in structure and function

Front 34

Malignant

Back 34

Neoplastic growth that invades and destroyes adjacent structures

Front 35

Metastasize

Back 35

Malignant neoplasms that travel to distant sites

Front 36

Sarcoma

Back 36

Highly malignant tumor originating from connective tissue

Front 37

Lymphatic spread

Back 37

Major routes by which carcinoma metastasizes

Front 38

Hemotogenous spread

Back 38

Malignant tumors that have invaded the circulatory system and travel as neoplastic emboli.

Front 39

Grading

Back 39

Assessment of aggressiveness or degree of malignancy

Front 40

Staging

Back 40

1 extensiveness of tumore at primary site 2 prescence or abscence of metastases to lymph nodes and distant organs

Front 41

Epidemiology

Back 41

Study of determinants of disease events in given populations

Front 42

Morbidity

Back 42

Rate that illness or abnormality occurs

Front 43

Morality

Back 43

Reflects the # of deaths by disease per population

Front 44

Antigen

Back 44

Foreign substance that evokes an immune response

Front 45

Antibodies

Back 45

Immunoglobins responding to antigens to make them harmless

Front 46

Immune

Back 46

Protected against antigens; antibodies binding with antigens to make them harmless

Front 47

Vaccine

Back 47

Contact with dead or deactivated microorganims to form antibodies

Front 48

Active immunity

Back 48

Forming antibodies to counteract an antigen by way of vaccine or toxoid

Front 49

Passive immunity

Back 49

Administration of dose of preformed antibdoies from the immune serum if an animal usually a horse

Front 50

Anaphylactic reactions

Back 50

Hypersensitive reaction resulting in antihistamine release

Front 51

Standard precautions

Back 51

Protection used when delivering healthcare service to any person

Front 52

PPE

Back 52

Gowns gloves masks shoe covers and eye protection used to prevent the trasmission of potential infectious agents

Front 53

Trasmission-based precautions

Back 53

Additional PPE to prevent the spread of highly infectious pathogens throughc contact, droplet, or airborne transmission